Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2 Study of GH001 in Patients With Treatment-Resistant Depression

NCT04698603 is registered in ClinicalTrials.gov with GH Research Ireland Limited as lead sponsor.

NCT NCT04698603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04698603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2 Study of GH001 in Patients With Treatment-Resistant Depression
Lead sponsor
GH Research Ireland Limited
Phase
Phase 1/2
Overall status
Completed
Start date
November 12, 2019
Completion date
November 6, 2021
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, major depressive disorder, treatment resistant depression